These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3564003)

  • 21. Association of mitotane with chylomicrons and serum lipoproteins: practical implications for treatment of adrenocortical carcinoma.
    Kroiss M; Plonné D; Kendl S; Schirmer D; Ronchi CL; Schirbel A; Zink M; Lapa C; Klinker H; Fassnacht M; Heinz W; Sbiera S
    Eur J Endocrinol; 2016 Mar; 174(3):343-53. PubMed ID: 26671975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bovine adrenal cortex transformations of mitotane [1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; o,p'-DDD] and its p,p'- and m,p'-isomers.
    Cai W; Benitez R; Counsell RE; Djanegara T; Schteingart DE; Sinsheimer JE; Wotring LL
    Biochem Pharmacol; 1995 May; 49(10):1483-9. PubMed ID: 7763292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The treatment of adrenocortical carcinoma with o,p'-DDD: prognostic implications of serum level monitoring.
    van Slooten H; Moolenaar AJ; van Seters AP; Smeenk D
    Eur J Cancer Clin Oncol; 1984 Jan; 20(1):47-53. PubMed ID: 6537915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recovery of adrenal function after treatment of adrenocortical carcinoma with o,p'-DDD.
    Greig F; Oberfield SE; Levine LS; Ghavimi F; Pang S; New MI
    Clin Endocrinol (Oxf); 1984 Apr; 20(4):389-99. PubMed ID: 6325050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete remission of metastasized adrenocortical carcinoma under o,p'-DDD.
    Kornely E; Schlaghecke R
    Exp Clin Endocrinol; 1994; 102(1):50-3. PubMed ID: 8005209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of mitotane (o,p'-DDD) in adrenal cortex hyperfunction].
    Kasperlik-Załuska A; Migdalska B
    Endokrynol Pol; 1982; 33(1-3):99-104. PubMed ID: 7183447
    [No Abstract]   [Full Text] [Related]  

  • 27. The distribution of o,p'-DDD (mitotane) among serum lipoproteins in normo- and hypertriglyceridemia.
    Gebhardt DO; Moolenaar AJ; van Seters AP; van der Velde EA; Gevers Leuven JA
    Cancer Chemother Pharmacol; 1992; 29(4):331-4. PubMed ID: 1537084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multiple recurrence of Cushing's syndrome after bilateral adrenalectomy and pituitary gland surgery. Cure with o,p'-DDD].
    Bigler U; Müller J
    Schweiz Med Wochenschr; 1978 Jan; 108(2):67-72. PubMed ID: 622536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study.
    Alexandraki KI; Kaltsas GA; le Roux CW; Fassnacht M; Ajodha S; Christ-Crain M; Akker SA; Drake WM; Edwards R; Allolio B; Grossman AB
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):305-11. PubMed ID: 19473175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cushing's syndrome due to adrenocortical carcinoma - a comphrensive clinical and biochemical study of patients treated by surgery and chemotherapy.
    Kelly WF; Barnes AJ; Cassar J; White M; Mashiter K; Loizou S; Welbourn RB; Joplin GF
    Acta Endocrinol (Copenh); 1979 Jun; 91(2):303-18. PubMed ID: 223356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The protracted effect of o,p'-DDD in Cushing's disease and its impact on adrenal morphogenesis of young human embryo.
    Leiba S; Weinstein R; Shindel B; Lapidot M; Stern E; Levavi H; Rusecki Y; Abramovici A
    Ann Endocrinol (Paris); 1989; 50(1):49-53. PubMed ID: 2729882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A high-pressure liquid chromatographic method for measuring mitotane [1,1-(o,p'-Dichlorodiphenyl)-2,2-dichloroethane] and its metabolite 1,1-(o,p'-Dichlorodiphenyl)-2,2-dichloroethene in plasma.
    Andersen A; Warren DJ; Nome O; Vesterhus L; Slørdal L
    Ther Drug Monit; 1995 Oct; 17(5):526-31. PubMed ID: 8585118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of o,p'-DDD on plasma ACTH concentration in Cushing's disease.
    Bruno OD; Hoschoian JC; Andrada JA
    Medicina (B Aires); 1979; 39(2):229-34. PubMed ID: 228150
    [No Abstract]   [Full Text] [Related]  

  • 34. Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma.
    Claps M; Cerri S; Grisanti S; Lazzari B; Ferrari V; Roca E; Perotti P; Terzolo M; Sigala S; Berruti A
    Endocrine; 2018 Jul; 61(1):169-172. PubMed ID: 29019062
    [No Abstract]   [Full Text] [Related]  

  • 35. Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma?
    Dickstein G; Shechner C; Arad E; Best LA; Nativ O
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3100-3. PubMed ID: 9745410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing's syndrome: in vivo and in vitro studies.
    Tsagarakis S; Tsigos C; Vassiliou V; Tsiotra P; Pratsinis H; Kletsas D; Trivizas P; Nikou A; Mavromatis T; Sotsiou F; Raptis S; Thalassinos N
    J Clin Endocrinol Metab; 2001 Feb; 86(2):583-9. PubMed ID: 11158012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corticoid production by four dogs with hyperfunctioning adrenocortical tumours during treatment with mitotane (o,p'-DDD).
    Rijnberk A; Voorhout G; Mol JA
    Vet Rec; 1992 Nov; 131(21):484-7. PubMed ID: 1471327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comment--Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma?
    Barzon L; Fallo F; Sonino N; Daniele O; Boscaro M
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1488-9. PubMed ID: 10199802
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasma cortisol profiles in Cushing's syndrome.
    Yoshida K; Satowa H; Sato A; Ichikawa Y; Kream J; Levin J; Zumoff B; Hellman L; Fukushima DK
    Acta Endocrinol (Copenh); 1979 Jun; 91(2):319-28. PubMed ID: 223357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-dimensional chromatography for enantiomeric analysis of mitotane and its metabolite o,p'-DDA in patients with adrenocortical carcinoma indicates enantioselective metabolism.
    Stadler G; de Almeida Veiga A; Rita Corso C; Bach de Assis C; de Toledo Nogueira B; Regina Rocha Martins L; Cruz Bonk B; Lada Degaut Pontes F; Cavalcante de Figueiredo B; Mera de Souza L
    Bioorg Chem; 2023 Dec; 141():106835. PubMed ID: 37713949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.